INMUNE BIO INC. - COMM
4.8800
26-November-24 15:45:00
15 minutes delayed
Stocks
+0.0800
+1.67%
Today's range
4.6800 - 4.9300
ISIN
N/A
Source
NASDAQ
-
13 Nov 2024 08:00:00 By Nasdaq GlobeNewswire
-
INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update
31 Oct 2024 15:05:51 By Nasdaq GlobeNewswire
-
INmune Bio Inc. to Host Webinar on Cognitive Testing Using EMACC and CDR-SB
28 Oct 2024 07:00:00 By Nasdaq GlobeNewswire
-
INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination
24 Oct 2024 14:03:00 By Nasdaq GlobeNewswire
-
24 Oct 2024 08:30:00 By Nasdaq GlobeNewswire
-
INmune Bio Inc. to Participate in the Maxim Healthcare Virtual Summit
11 Oct 2024 07:30:00 By Nasdaq GlobeNewswire
-
INmune Bio Inc. Completes Enrollment for Phase 2 Trial in Early Alzheimer's Disease
30 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
INKmune™ Demonstrates Excellent Safety and Increased NK-Cell Activity in First Dosing Cohort
26 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
17 Sep 2024 07:30:00 By Nasdaq GlobeNewswire
-
INmune Bio Announces $13.0 Million Registered Direct Offering
13 Sep 2024 07:30:00 By Nasdaq GlobeNewswire
-
INmune Bio Inc. to Present at the Baird 2024 Global Healthcare Conference
03 Sep 2024 08:00:00 By Nasdaq GlobeNewswire
-
INmune Bio Inc. Announces Second Quarter 2024 Results and Provides Business Update
01 Aug 2024 15:05:39 By Nasdaq GlobeNewswire
-
29 Jul 2024 08:00:00 By Nasdaq GlobeNewswire
-
25 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
23 Jul 2024 07:45:00 By Nasdaq GlobeNewswire
-
INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer’s Disease Trial
27 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
INmune Bio Inc. to Join Russell 3000® Index
30 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update
09 May 2024 15:05:36 By Nasdaq GlobeNewswire
-
07 May 2024 07:00:01 By Nasdaq GlobeNewswire
-
30 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >